Full text is available at the source.
Abstract
WDR5 abundance and baseline H3K4me3 levels are associated with sensitivity to combined HDAC and WDR5 WIN-pocket inhibition.
- Histone deacetylase inhibitors increase chromatin acetylation but show variable effectiveness in solid tumors.
- The study identifies the WDR5 WIN pocket as crucial for maintaining chromatin-associated COMPASS and promoter-proximal H3K4me3 levels.
- Disruption of the WDR5 WIN pocket leads to reduced recovery of COMPASS components and lower H3K4me3 at specific promoters.
- This disruption results in higher H3K27 acetylation, decreased H3K4me3, and diminished transcriptional output.
- Data indicate that HDAC inhibitor response may be influenced by promoter licensing through the WDR5-COMPASS H3K4 methylation axis.
Simplified